General Issues of Chirality in Pharmacology

Spasov, A. A.; Iezhitsa, Igor Nikolayevich; Vassiliev, Pavel M.; Озеров, А. А.; Agarwal, Renu

doi:10.1007/978-981-19-2320-3_3

Progress in Drug Research

2022

DOI: 10.1007/978-981-19-2320-3_3

|View full text |Cite

General Issues of Chirality in Pharmacology

A. A. Spasov¹,

Igor Nikolayevich Iezhitsa²,

Pavel M. Vassiliev³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 100 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Enantioselectivity in Pharmacokinetics: A Mini Review

Laldinchhana,

Lalrengpuii,

Komu

et al. 2024

Scopus Indexed

View full text Add to dashboard Cite

Enantiomerism or drug chirality is one of the major concerns in drug discovery and development since more than 50% of currently marketed drugs are chiral compounds. Chiral molecules are also called enantiomers where a molecule contains at least one asymmetric carbon. Chiral inversion is an important phenomenon in which an enantiomer may convert from one enantiomeric configuration to the other which can be unidirectional or bidirectional. Enantiomers, though similar in their chemical structure, show noticeable differences in their biological properties. Therefore, a thorough knowledge of racemic drugs is important in the drug developmental stages to eliminate inactive or toxic isomers. Different databases such as ‘ScienceDirect’ and ‘Google Scholar have been used to search the articles using keywords Absorption of chiral compounds; Chirality in pharmacology; Enantiomers; Enantioselectivity; and Pharmacokinetics. With the advancement in synthetic chemistry, the development of a single enantiomer could potentially improve the overall development and manufacturing process of drugs. The current review addresses the nomenclature and enantioselectivity of enantiomers in various pharmacokinetic parameters such as absorption, distribution, metabolism and excretion.

show abstract

Enantioselectivity in Pharmacokinetics: A Mini Review

Laldinchhana,

Lalrengpuii,

Komu

et al. 2024

Scopus Indexed

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

General Issues of Chirality in Pharmacology

Cited by 1 publication

References 100 publications

Enantioselectivity in Pharmacokinetics: A Mini Review

Enantioselectivity in Pharmacokinetics: A Mini Review

Contact Info

Product

Resources

About